Aixtron's Order Book Surges 80% — Yet the Share Chart Tells a Different Story

Aixtron's Q2 orders jump 80% to €214.5M, but revenue falls short and shares drop 29% in a month, highlighting market skepticism.

The Cologne-based deposition equipment maker Aixtron booked €214.5 million in new orders during the second quarter of 2026, a jump of 80% year-on-year that chief executive Felix Grawert described as marking a "significant turning point" for the company in the first half. Optoelectronics applications accounted for roughly three-quarters of the incoming orders, cementing that segment's role as the primary demand engine.

The headline numbers, however, only tell part of the story. While the order pipeline has refilled impressively, the income statement shows a business still finding its footing. After a loss-making first quarter, Aixtron swung back to a positive EBIT of €14.7 million in Q2. Revenue of €115.1 million came in below the roughly €137.4 million reported in the same period last year — a shortfall that has not gone unnoticed by the analyst community.

A Tale of Two Ratings

The divergence between operational momentum and share price performance has produced an unusual split among the banks covering the stock. Jefferies trimmed its price target from €73.00 to €55.30 on Friday while keeping its "Buy" recommendation intact. Berenberg Bank set a target of €42.00, and the DZ Bank also issued an updated assessment following the quarterly figures, though without explicitly stating a rating or target.

These downward revisions stand in contrast to the more bullish stance taken by a US bank, which recently initiated coverage with an "Overweight" rating and a €70 price objective. The differing targets — ranging from €42 to €73 — underscore the uncertainty surrounding how quickly the demand recovery will translate into sustained earnings growth.

Market Skepticism Persists

The share price response to the quarterly report was muted at best. The stock gained 3.06% on Friday to close at €36.38, a modest bounce that does little to repair the damage done over the past month. The shares remain down 29.25% over a 30-day horizon and sit nearly 42% below their 52-week high of €62.68, reached back in June. The equity continues to trade below its moving averages from recent months, a technical signal that suggests the correction may not yet be over.

The retreat follows a remarkable run that saw the stock more than double from the start of the year, and the subsequent volatility reflects broader nervousness around high-growth technology names. Aixtron has been a clear beneficiary of the optoelectronics cycle, but investors have shown they will punish any perceived wobble in the order flow of such cyclical businesses.

Expansion and New Customers

Beyond the financials, Aixtron has been quietly building out its global footprint. On July 23, the company announced plans for a new facility in Malaysia, following an earlier announcement in March about expanding its presence in the country to support the local semiconductor industry.

Customer wins have also been accumulating. The MIT Lincoln Laboratory purchased two 300-millimeter Hyperion systems in June for research into gallium nitride and 2D materials. Japanese chipmaker ROHM Semiconductor has been using Aixtron's G10-GaN platform since June to scale up production of GaN power devices. These orders from the power electronics space are viewed as evidence that demand is stabilizing across multiple customer segments rather than relying solely on the optoelectronics boom.

Financial Firepower and the Road Ahead

The company also strengthened its balance sheet in April, completing a €450 million convertible bond placement on April 15 — a day after management raised its full-year guidance and reported strong preliminary first-quarter results.

For 2026, the board continues to expect revenue of €560 million, with a variance of €30 million either way, and an EBIT margin between 17% and 20%. Management's decision to hold the forecast signals confidence internally, even as the recent round of analyst target cuts suggests the market remains cautious about second-half visibility.

The next major checkpoint comes on October 29, when Aixtron publishes its nine-month update. By then, investors will have a clearer read on whether the second-quarter return to profitability marks a durable recovery or merely a temporary respite in what could be a longer demand trough. The order book is pointing in the right direction; whether the share price follows will depend on how quickly that momentum shows up in the income statement.